U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 18:21:07 UTC 2021
Edited
by admin
on Sat Jun 26 18:21:07 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
K16AIQ8CTM
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
PERTUZUMAB
DASH   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Common Name English
RHUMAB-2C4
Code English
PERTUZUMAB [VANDF]
Common Name English
PERTUZUMAB [JAN]
Common Name English
RG-1273
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Common Name English
PERTUZUMAB [USAN]
Common Name English
PERJETA
Brand Name English
PERTUZUMAB [PURPLE BOOK, CDER]
Common Name English
PERTUZUMAB [MART.]
Common Name English
RHUMAB 2C4
Code English
PERTUZUMAB [INN]
Common Name English
PERTUZUMAB [MI]
Common Name English
PERTUZUMAB (GENETICAL RECOMBINATION)
JAN  
Official Name English
PERTUZUMAB [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 284409
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
WHO-VATC QL01XC13
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
NCI_THESAURUS C155711
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
WHO-ATC L01XC13
Created by admin on Sat Jun 26 18:21:07 UTC 2021 , Edited by admin on Sat Jun 26 18:21:07 UTC 2021
FDA ORPHAN DRUG 400713
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
NDF-RT N0000175661
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
Code System Code Type Description
INN
8380
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY
LACTMED
Pertuzumab
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY
DRUG CENTRAL
4957
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY
JAPANESE REVIEW
PERJETA
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY APPROVED JUNE 2013
MESH
C485206
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY
ChEMBL
CHEMBL2007641
Created by admin on Sat Jun 26 18:21:07 UTC 2021 , Edited by admin on Sat Jun 26 18:21:07 UTC 2021
PRIMARY
FDA UNII
K16AIQ8CTM
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY
NCI_THESAURUS
C38692
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY
RXCUI
1298944
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY RxNorm
CAS
380610-27-5
Created by admin on Sat Jun 26 18:21:07 UTC 2021 , Edited by admin on Sat Jun 26 18:21:07 UTC 2021
PRIMARY
EVMPD
SUB16455MIG
Created by admin on Sat Jun 26 18:21:07 UTC 2021 , Edited by admin on Sat Jun 26 18:21:07 UTC 2021
PRIMARY
HSDB
8141
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY
WIKIPEDIA
PERTUZUMAB
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY
MERCK INDEX
M8568
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY Merck Index
DRUG BANK
DB06366
Created by admin on Sat Jun 26 18:21:07 UTC 2021 , Edited by admin on Sat Jun 26 18:21:07 UTC 2021
PRIMARY
IUPHAR
5046
Created by admin on Sat Jun 26 18:21:08 UTC 2021 , Edited by admin on Sat Jun 26 18:21:08 UTC 2021
PRIMARY
From To
1_22 1_96
1_146 1_202
1_222 3_214
1_228 2_228
1_231 2_231
1_263 1_323
1_369 1_427
2_22 2_96
2_146 2_202
2_222 4_214
2_263 2_323
2_369 2_427
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Related Record Type Details
TARGET -> INHIBITOR
HER dimerization inhibitor
BINDING
SUB_CONCEPT->SUBSTANCE
LABELED -> NON-LABELED
INHIBITOR -> TARGET
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE(CALCULATED) CHEMICAL
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC